Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker.
about
Proteomics and peptidomics: moving toward precision medicine in urological malignanciesProgress of molecular targeted therapies for prostate cancersA Novel Role of Lamins from Genetic Disease to Cancer BiomarkersQuantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progressionPlumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cellsDifferential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer ProgressionTransient nuclear envelope rupturing during interphase in human cancer cells.Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics dataConstruction and analysis of protein-protein interaction networks based on proteomics data of prostate cancerProstate cancer proteomics: Current trends and future perspectives for biomarker discovery.The lamin protein family.The nuclear envelope environment and its cancer connections.Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS.Proteomics of cancer stem cells.Nuclear mechanics in cancerConcentration-dependent Effects of Nuclear Lamins on Nuclear Size in Xenopus and Mammalian Cells.Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancerNuclear lamins in cancerNuclear morphometry, nucleomics and prostate cancer progressionCancer metabolism: what we can learn from proteomic analysis by mass spectrometry.Novel approaches for the identification of biomarkers of aggressive prostate cancerSizing and shaping the nucleus: mechanisms and significance.Do lamin A and lamin C have unique roles?Intracellular kinetics of the androgen receptor shown by multimodal Image Correlation Spectroscopy (mICS).Causes and consequences of nuclear envelope alterations in tumour progression.Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis.Development of a label-free LC-MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy.Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticityDistinct 3D Structural Patterns of Lamin A/C Expression in Hodgkin and Reed-Sternberg Cells
P2860
Q26749401-BCA9CD76-9A14-43D0-AA22-49902DDFE192Q26823014-4D93882A-8298-49E8-8A03-8B7EAC0FFEBDQ28072459-A5A52AD9-907A-4B19-96A7-2961D529E280Q28286300-ED864F72-D027-4EDB-BC03-C7EC5CB07FCEQ28385880-44C92844-CD92-439C-B3DE-559021D08425Q28550287-093A9421-4C3C-4C39-8775-BAE14FF407D3Q30513945-CE96CD92-F7BF-45D9-AB15-BD6ED42C4CDDQ31070165-C1FB22C9-A81D-45CC-B0FA-0EC0F1611704Q31086270-775968FE-810A-4229-AD60-0483B2AD6E69Q33567004-D229F8AA-1ED4-42A2-BF31-C7663C8C516EQ34189692-64D2E4F3-F605-4C46-981A-F02B7718ED0FQ34254678-FCF0EA9D-4EF1-48F2-9BA0-39C0C05B61C0Q35033878-1403A805-70AD-48F0-8335-12B49C6B881CQ35071416-6EF2AA8A-DC77-4C24-A13D-2A6CAF5762D5Q36116300-122C5736-86CB-4A1A-9638-771F3E4ACE14Q36282862-9102A66C-5B30-4858-8CE5-C970EF160589Q36298306-888391BF-D109-46A6-B75A-A80960673D56Q37207687-F495BACF-C987-47E2-B0A0-7905C483D33AQ38002780-D08BA7A6-862B-4476-AFE9-2F545851D47BQ38060693-E4C6C6D2-D0ED-4586-9D32-5743040981D2Q38117841-E773BBC7-5103-4F95-9A74-D0A543F0A451Q38185842-B723DD0A-7B56-4542-B2C9-1F743D4C13FBQ38256841-3BE4841F-12D3-4B7E-964A-16D64333B8EBQ38744269-8D07ABE7-4A6A-4082-8816-A3A82CF61C7FQ38891711-464E0329-834C-4B9B-9A59-21614E7D8384Q39226627-F41CDE95-195B-43D1-819F-306E39751C94Q50996571-9D0A37E6-1B14-4A90-B435-B9904418EC20Q58698836-CDAB2E39-DF2A-470F-AB6C-3181BBE2D730Q58704318-55BBCC4B-5E49-47BE-9606-C38BCAD5AF7E
P2860
Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proteomics profiling of microd ...... as a discriminatory biomarker.
@ast
Proteomics profiling of microd ...... as a discriminatory biomarker.
@en
type
label
Proteomics profiling of microd ...... as a discriminatory biomarker.
@ast
Proteomics profiling of microd ...... as a discriminatory biomarker.
@en
prefLabel
Proteomics profiling of microd ...... as a discriminatory biomarker.
@ast
Proteomics profiling of microd ...... as a discriminatory biomarker.
@en
P2093
P356
P1476
Proteomics profiling of microd ...... as a discriminatory biomarker.
@en
P2093
Georg Bartsch
Georg Schäfer
Guenther Karl Bonn
Helmut Klocker
Lukas Alfons Huber
Sergej Skvortsov
Taras Stasyk
P304
P356
10.1021/PR100921J
P577
2010-11-16T00:00:00Z